Sparsentan (SPAR) Added to Stable Sodium-Glucose Cotransporter-2 Inhibitors (SGLT2is) in Adults With IgA Nephropathy (IgAN) in the Phase 2 SPARTACUS Trial
62nd European Renal Association (ERA) Congress 2025
June 6 - 7, 2025
Austria
ASN Update
Concomitant Sparsentan and Sodium-Glucose Cotransporter-2 Inhibitors in Adults With IgA Nephropathy in the Ongoing Phase 2 SPARTACUS Trial
American Society of Nephrology (ASN) Kidney Week 2024
October 23 - 27, 2024
CA